Nasopharyngeal carriage of children 6 to 60 months during the implementation of the 13-valent pneumococcal conjugate vaccine;Portage rhinopharyngé d'enfants âgés de six à 60 mois durant l'implémentation du vaccin pneumococcique conjugué 13-valent

Archives de Pediatrie

Volumn 19, Issue 10, 2012, Pages 1132-1139

  Cohen, R ^a,b   Levy, C ^a   Bingen, E ^c   Bechet, S ^a   Derkx, V ^a   Werner, A ^d   Koskas, M ^a   Varon, E ^e  

^a Association clinique et therapeutique infantile du Val de Marne ACTIV   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d AFPA Association Francaise de Pediatrie Ambulatoire   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ARTICLE; BACTERIAL COLONIZATION; CHILD; CHILD HEALTH CARE; CLINICAL EVALUATION; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; HEALTH CARE PLANNING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MORAXELLA CATARRHALIS; NASOPHARYNX; NONHUMAN; NOSE SMEAR; PRESCHOOL CHILD; SIBLING; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE; TREND STUDY; VACCINATION;

CARRIER STATE; CASE-CONTROL STUDIES; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; FEMALE; FRANCE; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; MALE; MULTIVARIATE ANALYSIS; NASOPHARYNX; OTITIS MEDIA; PNEUMOCOCCAL VACCINES; SIBLINGS; STREPTOCOCCUS PNEUMONIAE;

EID: 84866752003     PISSN: 0929693X     EISSN: 1769664X     Source Type: Journal    
DOI: 10.1016/j.arcped.2012.07.013     Document Type: Article

References (17)

1. Shouval D.S., Greenberg D., Givon-Lavi N., et al. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 2006, 25(7):602-607.
2. Greenberg D., Givon-Lavi N., Newman N., et al. Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric pneumonia as a means to estimate serotype disease potential. Pediatr Infect Dis J 2011, 30(3):227-233.
3. Cohen R., Levy C., de La Rocque F., et al. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J 2006, 25(11):1001-1007.
4. Cohen R., Levy C., Bonnet E., et al. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine 2010, 28(37):6114-6121.
5. Cohen R., Bingen E., Levy C., et al. Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France. BMC Infect Dis 2012, 12(1):52.
6. Cohen R., Levy C., Bingen E., et al. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatr Infect Dis J 2012, 31(3):297-301.
7. Cohen R., Levy C., Bonnet E., et al. Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination. BMC Infect Dis 2011, 11:95.
8. Cohen R., Levy C., Boucherat M., et al. Enquête épidémiologique sur l'OMA en pratique de ville. Med Enf 1996, 16:27-31.
9. Scheifele D., Halperin S., Pelletier L., et al. Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT). Clin Infect Dis 2000, 31(1):58-64.
10. Paradise J.L. On classifying otitis media as suppurative or nonsuppurative, with a suggested clinical schema. J Pediatr 1987, 111(6 Pt 1):948-951.
11. Anonymous. http://www.has-sante.fr/portail/jcms/c_957703/prevenar-13-vaccin-anti-pneumococcique. 2010.
12. Gaudelus J., Cohen R. évolution de la couverture vaccinale du vaccin pneumococcqiue conjugué de 2006 à 2010: analyse des carnets de santé. Med Enf 2011, 187-190.
13. Varon E., Janoir C., Gutmann L., et al. Rapport d'activité 2010. Epidémiologie 2009, http://www.invs.sante.fr/content/.../18785/.../Rapport+CNRP2010_Web.pdf.
14. Tocheva A.S., Jefferies J.M., Rubery H., et al. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children. Vaccine 2011, 29(26):4400-4404.
15. Weinberger D.M., Malley R., Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011, 378(9807):1962-1973.
16. Levy C., Thollot F., Corrard F., et al. Acute otitis media in ambulatory practice: epidemiological and clinical characteristics after 7 valent pneumococcal conjugate vaccine (PCV7) implementation. Arch Pediatr 2011, 18(6):712-718.
17. Trotter C.L., Waight P., Andrews N.J., et al. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006. J Infect 2010, 60(3):200-208.